TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$5.58M2015: -$238.88M2016: -$124.50M2017: -$99.12M2018: -$98.39M2019: -$156.25M2020: -$220.88M2021: -$330.28M2022: -$351.30M2023: -$362.25M2024: -$344.18M2025: -$256.03M-$256.03M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$256.03M+25.6%
2024-$344.18M+5.0%
2023-$362.25M-3.1%
2022-$351.30M-6.4%
2021-$330.28M-49.5%
2020-$220.88M-41.4%
2019-$156.25M-58.8%
2018-$98.39M+0.7%
2017-$99.12M+20.4%
2016-$124.50M+47.9%
2015-$238.88M-4184.8%
2014-$5.58M—